| 000 | 00964 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517185418.0 | ||
| 264 | 0 | _c20180314 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1464-410X | ||
| 024 | 7 |
_a10.1111/bju.14069 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDasgupta, Prokar | |
| 245 | 0 | 0 |
_aNICE guidance and the BJUI. _h[electronic resource] |
| 260 |
_bBJU international _c12 2017 |
||
| 300 |
_a743 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJournal Impact Factor |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPeriodicals as Topic |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xpathology |
| 650 | 0 | 4 |
_aState Medicine _xstandards |
| 650 | 0 | 4 | _aUnited Kingdom |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xpathology |
| 773 | 0 |
_tBJU international _gvol. 120 _gno. 6 _gp. 743 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bju.14069 _zAvailable from publisher's website |
| 999 |
_c27818209 _d27818209 |
||